
ELI LILLY AND COMPAN
LLY
![]() |
|
190.77USD | +2.19% |
Turn to zoom
Prev. | 186.6900 |
Open | 186.8000 |
High | 191.7800 |
Low | 186.8000 |
Volume | 4 413 184 |
Latest news
Chart ELI LILLY AND COMPANY
Technical analysis trends
Short Term | Mid-Term | Long Term | |
Trend | Bullish | Bullish | Bullish |
Resistance | 206 | 214 | 196 |
Spread/Res. | -7,3% | -11% | -2,7% |
Spread/Supp. | 21% | 21% | 24% |
Support | 158 | 158 | 154 |
Financials
|
|
Company
Eli Lilly and Company is engaged in drug manufacturing business. The Company discovers, develops, manufactures and markets products in two segments: human pharmaceutical products and animal health products. The Company's human pharmaceutical business segment sells medicines, which are discovered or...
>> Read more
>> Read more
Sector : |
Pharmaceuticals - NEC
|
Calendar : |
2021-01-29 Earnings Release
|
Trading Rating : |
Investor Rating : |
Income Statement Evolution
Consensus
Mean consensus | OUTPERFORM |
Number of Analysts | 20 |
Average target price | 181,58 $ |
Last Close Price | 190,77 $ |
Spread / Highest target | 19,0% |
Spread / Average Target | -4,82% |
Spread / Lowest Target | -37,1% |